What is the antiviral nasal spray for COVID? Exploring options and clinical trials
•
5 min read
A Phase 2 clinical trial published in September 2025 found that the antihistamine azelastine nasal spray was associated with a significantly reduced risk of SARS-CoV-2 infection. This recent finding highlights the scientific effort to find out what is the antiviral nasal spray for COVID.
